Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA

Clinical Orthopaedics and Related Research

Volumn 470, Issue 1, 2012, Pages 138-143

  DiIorio, Timothy M ^a   Burkholder, Justin D ^b   Good, Robert P ^c   Parvizi, Javad ^d   Sharkey, Peter F ^d  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY   (United States)

^c BRYN MAWR HOSPITAL   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; MORPHINE; MORPHINE SULFATE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GEL; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; POSTOPERATIVE ANALGESIA; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANGE OF MOTION; RISK REDUCTION; SURGICAL PATIENT; THROMBOCYTE RICH PLASMA; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; VERY ELDERLY; WOUND; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FOLLOW UP; INCIDENCE; JOINT CHARACTERISTICS AND FUNCTIONS; KNEE ARTHROPLASTY; METHODOLOGY; PAIN ASSESSMENT; PEROPERATIVE CARE; PHYSIOLOGY; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX RATIO; THROMBOCYTE TRANSFUSION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PLATELET TRANSFUSION; PLATELET-RICH PLASMA; POSTOPERATIVE HEMORRHAGE; RANGE OF MOTION, ARTICULAR; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 84865090277     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-1972-1     Document Type: Conference Paper

References (16)

1. Bengston S, Knutson K, Lidgren L. Treatment of infected knee arthroplasty. Clin Orthop Relat Res. 1989;245:173-178.
2. Berghoff WJ, Pietrzak WS, Rhodes RD. Platelet-rich plasma application during closure following total knee arthroplasty. Orthopedics. 2006;29:590-598.
3. Berman AT, Geissele AE, Bosacco SJ. Blood loss with total knee arthroplasty. Clin Orthop Relat Res. 1988;234:137-138.
4. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999;21:2-10.
5. Blumberg N, Heal JM. Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am J Med. 1996; 101:299-308.
6. Dennis DA. Wound complications in total knee arthroplasty. Instr Course Lect. 1997;46:165-169.
7. Everts PA, Devilee RJ, Brown Mahoney C, Eeftinck-Schattenkerk M, Box HA, Knape JT, van Zundert A. Platelet gel and fibrin sealant reduce allogeneic blood transfusions in total knee arthroplasty. Acta Anaesthesiol Scand. 2006;50:593-599.
8. Gardner MJ, Demetrakopoulos D, Klepchick PR, Mooar PA. The efficacy of autologous platelet gel in pain control and blood loss in total knee arthroplasty. An analysis of the haemoglobin, narcotic requirement and range of motion. Int Orthop. 2007;31:309-313.
9. Hill GE, Frawley WH, Griffith KE, Forestner JE, Minei JP. Allogenic blood transfusion increases the risk of postoperative bacterial infection: A meta-analysis. J Trauma Injury Infect Crit Care. 2003;54:908-914.
10. Horstmann WG, Slappendel R, van Hellemondt GG, Wymenga AW, Jack N, Everts PA. Autologous platelet gel in total knee arthroplasty: A prospective randomized study. Knee Surg Sports Traumatol Arthrosc. 2011;19:115-121.
11. Levy O, Martinowitz U, Oran A, Taber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg Am. 1999;81: 1580-1588.
12. Lotke PA, Faralli VJ, Orenstein EM, Ecker ML. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Joint Surg Am. 1991;73:1037-1040.
13. Mylod AG Jr, France MP, Muser DE, Parsons Jr. Perioperative blood loss associated with total knee arthroplasty. A comparison of procedures performed with and without cementing. J Bone Joint Surg Am. 1990;72:1010-1012.
14. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996;334:1685-1690.
15. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: A brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001;83:1503-1505.
16. Weiss AP, Krackow KA. Persistent wound drainage after primary total knee arthroplasty. J Arthroplasty. 1993;8:285-289.